BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25198048)

  • 1. Inhibiting Janus kinases to treat alopecia areata.
    Divito SJ; Kupper TS
    Nat Med; 2014 Sep; 20(9):989-90. PubMed ID: 25198048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune disease: Getting to the root of hair loss in alopecia.
    Bray N
    Nat Rev Drug Discov; 2014 Oct; 13(10):724-5. PubMed ID: 25233992
    [No Abstract]   [Full Text] [Related]  

  • 3. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.
    Xing L; Dai Z; Jabbari A; Cerise JE; Higgins CA; Gong W; de Jong A; Harel S; DeStefano GM; Rothman L; Singh P; Petukhova L; Mackay-Wiggan J; Christiano AM; Clynes R
    Nat Med; 2014 Sep; 20(9):1043-9. PubMed ID: 25129481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Janus kinase inhibitors: An innovative treatment for alopecia areata.
    Park H; Yu DA; Kwon O
    J Dermatol; 2019 Aug; 46(8):724-730. PubMed ID: 31237712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata.
    Blume-Peytavi U; Vogt A
    EBioMedicine; 2015 Apr; 2(4):282-3. PubMed ID: 26137570
    [No Abstract]   [Full Text] [Related]  

  • 6. Janus kinase inhibitors for alopecia areata: A narrative review.
    Haughton RD; Herbert SM; Ji-Xu A; Downing L; Raychaudhuri SP; Maverakis E
    Indian J Dermatol Venereol Leprol; 2023; 89(6):799-806. PubMed ID: 37436019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK Inhibitors for Treatment of Alopecia Areata.
    Wang EHC; Sallee BN; Tejeda CI; Christiano AM
    J Invest Dermatol; 2018 Sep; 138(9):1911-1916. PubMed ID: 30057345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of the histopathology and immunology of alopecia areata: Unearthing the role of the Janus kinase-signal transducer and activator of transcription pathway.
    Bansal A; Relhan V; Garg VK; Saran RK
    Indian J Dermatol Venereol Leprol; 2019; 85(5):455-461. PubMed ID: 31031313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata.
    Tavakolpour S
    Scand J Immunol; 2016 May; 83(5):345-6. PubMed ID: 26939767
    [No Abstract]   [Full Text] [Related]  

  • 10. Janus Kinase Inhibitors in the Treatment of Alopecia Areata.
    Stefanis AJ
    Prague Med Rep; 2023; 124(1):5-15. PubMed ID: 36763827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.
    Trüeb RM; Dias MFRG
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):68-87. PubMed ID: 28717940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.
    Jabbari A; Dai Z; Xing L; Cerise JE; Ramot Y; Berkun Y; Sanchez GA; Goldbach-Mansky R; Christiano AM; Clynes R; Zlotogorski A
    EBioMedicine; 2015 Apr; 2(4):351-5. PubMed ID: 26137574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata.
    Gordon SC; Abudu M; Zancanaro P; Ko JM; Rosmarin D
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e156-e157. PubMed ID: 30520145
    [No Abstract]   [Full Text] [Related]  

  • 14. [Janus kinase inhibitors for the treatment of alopecia areata].
    Kobal I; Ramot Y
    Hautarzt; 2022 May; 73(5):336-343. PubMed ID: 35482047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata.
    Bayart CB; DeNiro KL; Brichta L; Craiglow BG; Sidbury R
    J Am Acad Dermatol; 2017 Jul; 77(1):167-170. PubMed ID: 28619556
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of janus kinase inhibitors in the treatment of alopecia areata.
    Triyangkulsri K; Suchonwanit P
    Drug Des Devel Ther; 2018; 12():2323-2335. PubMed ID: 30100707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Janus kinase inhibitors: A review of applications in dermatology.
    Hosking AM; Juhasz M; Mesinkovska NA
    J Am Acad Dermatol; 2018 Sep; 79(3):535-544. PubMed ID: 29673776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for alopecia areata: JAK inhibitors.
    Iorizzo M; Tosti A
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):77-81. PubMed ID: 29466675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and Emerging Therapies for Alopecia Areata.
    Pourang A; Mesinkovska NA
    Drugs; 2020 May; 80(7):635-646. PubMed ID: 32323220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.